The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions):
7 December 31, 2016 7
7 4 Netting 5 Fair Value 7
7 Level 1 Level 2 Level 3 Other Adjustment Measurements 7
Assets:
Trading securities‘ $ 202 $ 115 $ 4 $ 63 $ — $ 384
Available-for—sale securities1 1,655 4,619 139 3 — — 6,413
Derivatives2 4 878 — — (369) 6 5 13 3
Total assets $ 1,861 $ 5,612 $ 143 $ 63 $ (369) $ 7,310
Liabilities:
7 Derivatives2 $ 11 $ 276 $ — $ — $ (192) 7 $ 95 7 3
7 Total liabilities $ 11 $ 276 $ — $ — $ (192) $ 95 7
1 Refer to Note 3 for additional information related to the composition of our trading securities and available—for—sale securities.
2 Refer to Note 5 for additional information related to the composition of our derivative portfolio.
3 Primarily related to long-term debt securities that mature in 2018.
4 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been
categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 3.
5 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative
positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master
netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.
6 The Company is obligated to return $201 million in cash collateral it has netted against its derivative position.
7 The Company has the right to reclaim $17 million in cash collateral it has netted against its derivative position.
8 The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $347 million in the
line item prepaid expenses and other assets; $166 million in the line item other assets; $42 million in the line item accounts payable and
accrued expenses; and $53 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of
our derivative portfolio.
December 31, 2015
4 Netting 5 Fair Value
7 Level 1 Level 2 Level 3 Other Adjustment Measurements 7
Assets:
Trading securities‘ $ 183 $ 101 $ 2 $ 36 $ — $ 322
Available-for—sale securities1 3,913 4,574 1 19 3 — — 8,606
7 Derivatives2 2 1,268 — — (638) 6 632 7 3
7 Total assets $ 4,098 $ 5,943 $ 121 $ 36 $ (63 8) $ 9,560 7
Liabilities:
Derivatives2 $ 24 $ 635 $ — $ — $ (488) 7 $ 171 3
7 Total liabilities $ 24 $ 635 $ — $ — $ (488) $ 171 7
1 Refer to Note 3 for additional information related to the composition of our trading securities and available—for—sale securities.
2 Refer to Note 5 for additional information related to the composition of our derivative portfolio.
3 Primarily related to long-term debt securities that mature in 2018.
4 Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been
categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 3.
5 Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative
positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master
netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.
6 The Company is obligated to return $184 million in cash collateral it has netted against its derivative position.
7 The Company has the right to reclaim $17 million in cash collateral it has netted against its derivative position.
8 The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $79 million in the
line item prepaid expenses and other assets; $553 million in the line item other assets; and $171 million in the line item other liabilities.
Refer to Note 5 for additional information related to the composition of our derivative portfolio.
128